TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH SUBCUTANEOUS HEPARIN AT LOW-DOSES

[1] BARROWCLIFFE TW, 1977, THROMB RES, V12, P27

[2] CAPRISSI LF, 1986, PRENSA MED ARGENT, V73, P13

[3] DEFISHER L, 1938, STATISTICAL TABLES B

[4] ENGELBERG H, 1983, ADV LIPID RES, V20, P219

[5] ERLI A, 1976, LANCET, P342

[6] GENTON E, 1983, CONCEPTOS MODERNOS E, V52, P45

[7] JAQUES LB, 1982, TRENDS PHARMACOL SCI, V3, P289, DOI 10.1016/0165-6147(82)91139-7

[8] 4 HEPARIN PREPARATIONS - ANTI-XA POTENTIATING EFFECT OF HEPARIN AFTER SUBCUTANEOUS INJECTION [J]. THROMBOSIS AND HAEMOSTASIS, 1976, 35 (03) : 586 - 591

[9] NEUMAN J, 1984, REV ARG CARDIOL, V52, P116

[10] Ruggiero H A, 1969, Prensa Med Argent, V56, P1411

[1] BARROWCLIFFE TW, 1977, THROMB RES, V12, P27

[2] CAPRISSI LF, 1986, PRENSA MED ARGENT, V73, P13

[3] DEFISHER L, 1938, STATISTICAL TABLES B

[4] ENGELBERG H, 1983, ADV LIPID RES, V20, P219

[5] ERLI A, 1976, LANCET, P342

[6] GENTON E, 1983, CONCEPTOS MODERNOS E, V52, P45

[7] JAQUES LB, 1982, TRENDS PHARMACOL SCI, V3, P289, DOI 10.1016/0165-6147(82)91139-7

[8] 4 HEPARIN PREPARATIONS - ANTI-XA POTENTIATING EFFECT OF HEPARIN AFTER SUBCUTANEOUS INJECTION [J]. THROMBOSIS AND HAEMOSTASIS, 1976, 35 (03) : 586 - 591

[9] NEUMAN J, 1984, REV ARG CARDIOL, V52, P116

[10] Ruggiero H A, 1969, Prensa Med Argent, V56, P1411